Persistent modest elevation of high‐sensitivity cardiac troponins I and T (hs‐cTnI, hs‐cTnT) is an established biomarker for detecting subclinical myocardial damage in ischaemic and non‐ischaemic cardiomyopathies [15, 16, 17]. Here, TNNT2 is linked to cardiomyopathy.